HCMHutchmedSigning up patients
HMPL-A830 in Solid Tumors
Solid Tumor, Adult
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 1/2
- Patients
- 147 (planned)
- Started
- Sep 24, 2026
- Main results expected
- May 23, 2029
- Fully finished
- Dec 15, 2029
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
DLTs
Measured over: Approximately 12 months
Overview of Treatment-emergent Adverse Events (TEAEs)
Measured over: Approximately 12 months
Objective Response Rate (ORR)
Measured over: Approximately 24 months
Recommended doses for phase II or III studies (RP2D or RP3D)
Measured over: Approximately 12 months
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT07718581 · record last updated 2026-10-01 · checked 2026-11-09 15:36 UTC